CHINA PHARMA HOLDINGS, INC. Lessor, Operating Lease, Payment to be Received, Year Two
CHINA PHARMA HOLDINGS, INC. (CPHI) had Lessor, Operating Lease, Payment to be Received, Year Two of $88.08 thousand as of 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Notes › Leases › Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity
us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears · last filed 2021-11-12
- 2021-09-30: Lessor, Operating Lease, Payment to be Received, Year Two $88.08K.
| Period end | Lessor, Operating Lease, Payment to be Received, Year Two |
|---|---|
| 2021-09-30 | $88.08K 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |